From market decision to first order.
IB7 works the market with you, phase by phase. You buy only as much of IB7 as your decision needs.
Every phase has two halves.
Evidence alone does not open a door, and introductions alone do not justify capital. Each phase delivers both.
Market intelligence
The evidence behind the decision, presented as fit bands, ranked shortlists, regulatory traffic lights, landed-cost waterfalls and routing maps — so a board can read the result without reading the method.
Action in the market
IB7 opens doors and works beside you — with importers, distributors, trade commissioners, consulates, chambers and host organizations — and supports your funding applications.
Each phase ends at a gate. You decide whether to continue.
Every phase starts from what your company already built — in the IB7 EDGE Workshop, or on your own — and deepens it.
Is this market worth it?
Candidate markets ranked against each other on evidence, with tariff exposure mapped and a clear verdict — including the verdict that you should not go.
How do we enter?
Entry mode, landed cost, regulatory pathway and funding fit decided together, with the first ninety days of cash set out.
Who buys?
A vetted partner shortlist and the introductions behind it — with IB7 at the table for the partner meetings, not just on the briefing note.
Is the thesis holding?
A launch gate, a dashboard that shows whether reality matches the plan, and a mid-course correction when it does not.
Fast-Track
Explore and Develop combined in about eight weeks, for companies that need a plan fast.
Most begin with a Brief, not a mandate.
Four phases taught in a cohort, working on your own company.
One-to-one, within 14 days of a session, to work through what it raised.
One market — a country, or a region that trades as one — researched and scored. The first purchase for most companies.
One phase or all four, scoped to the decision in front of you.
Soft Landing and Air Cargo, contracted separately as extras to the plan.
Smaller pieces, when a full phase is more than you need.
One market, researched and scored, with the outputs a decision actually needs.
Ninety minutes, one-to-one, on where your tariff exposure actually sits and what to do first.
Whether a U.S. presence changes your exposure, and what shape it would take.
A research question answered to a standard that can be published or submitted.
A recurring read on policy, tariff and incentive movement across the corridor.
When the decision is made and the market has to exist — entity, tax, compliance, IP.
Scoped per company.
Engagement phases are scoped and quoted against a written scope before any work begins. The Country Market Brief and the Tariff Response Clinic are fixed-price entry products — ask and we will send the current figures with the scope attached.
Funding
Your company may qualify for programs such as CanExport SMEs, which can cover part of eligible market-entry costs. Agri-food companies are usually pointed to AgriMarketing instead. Eligibility is decided by the program, not by IB7 — and IB7 can help you prepare the application.
Three engagements, described by sector.
Named references are published only with each client's written consent. Until then, the work speaks by shape rather than by name.
Sourcing and supplier qualification into Canada, carried from shortlist through to first shipments.
Market selection and partner identification for entry into Mexico and the United States.
A commissioned report on corridor conditions, delivered to an institutional standard.
Start with thirty minutes.
You describe the decision in front of you. We tell you which phase you are in, what would close it, and whether a Brief answers the question more cheaply than an engagement.
Book a free 30-minute readoutIB7 outputs are indicative and built on public data. They are not legal, tax, customs, regulatory or investment advice, and IB7 does not guarantee market results. Regulated work is carried out by licensed firms in each country.